OHK Medical Devices has awarded contract to Henry Schein Medical, the US physician business of Henry Schein Inc, for the exclusive distribution of HemaClear in the US alternate care market.

HemaClear is the surgical tourniquet single-use device that exsanguinates, occludes, and provides a clearer surgical field with ease of use and simplicity saving operating room time.

HemaClear provides a larger, dryer, and clearer surgical field, thereby providing the surgeon with a better view of anatomical structures and prepares any limb for surgery in less than 12 seconds.

Henry Schein Medical president Dave McKinley said this innovative new technology is simple, sterile, safe, cost-effective, and ultimately provides more successful surgical outcomes, especially for their customers that practice in ambulatory surgical settings and perform office-based procedures.